Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Uncontrolled Asthma and Nasal Polyposis
NCT02906761Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2019
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in asthma, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Asthma Control Questionnaire 6 at 6 months. Started Jan 2019; status: completed.
02
Drugs
aspirin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02906761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906761.